Michael Garren, MD retweeted
It is hard to imagine that cutting away a portion of the stomach could prevent future Alzheimer’s Disease but here, in our first of many stories to come, we show just that! SG’s effects on the brain are profound and long lasting! @LammingLab @WiscSurgery
onlinelibrary.wiley.com/doi/…
Michael Garren, MD retweeted
We are beyond excited to welcome @Kayla_Councell and @lindsaygil6 as the 2027 #MIS/#bari/#foregut and #Hernia fellows! Welcome to @WiscSurgery and to the best MIS family around! #onWisconsin @uchicagosurgery @OhioStateSurg @FellowshpCouncl
Age and Visceral Fat May Trend Together: What to Know medscape.com/viewarticle/age…
@WiscSurgery
1
51
See this Instagram post by @uw_health instagram.com/reel/DKSC7lQPL…
1
63
Michael Garren, MD retweeted
GLP-1s won’t replace surgery—but they’re changing how, when, and who we operate on.
Experts outline a hybrid future for obesity care at #ACSCC2025
🔗 generalsurgerynews.com/a/ADU… #GLP1
Michael Garren, MD retweeted
Dr. Michael Garren, professor in @WiscMIS, recently spoke about the importance of preparing your own meals, moving away from processed foods, and exercise. go.wisc.edu/q3a71x
Michael Garren, MD retweeted
Among US adults with class II/III #obesity, bariatric surgery was associated with greater weight loss and lower costs than #GLP-1 receptor agonists, with GLP-1 therapy initiated in 1 in 10 post-surgical patients.
Watch the video and learn more in these JAMA Surgery studies: ⬇️
Cancer Before 40: Michelle Robinson Story youtu.be/-27gdcp1CZI?si=iPiT… via @YouTube
A powerful story of the value of bariatric surgery and dealing with a cancer diagnosis. @UWHealth
Cardiovascular Outcomes and Mortality of Bariatric Surgery versus Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review and Meta-analysis - Surgery for Obesity and Related Diseases soard.org/article/S1550-7289…
47
Michael Garren, MD retweeted
GLP-1s are changing obesity care—but surgery is still the gold standard.
#ACSCC2025 experts say surgical treatment offers greater, longer-lasting results for many patients.
Read more: generalsurgerynews.com/a/zjM… #BariatricSurgery #ObesityCare #GLP1
Michael Garren, MD retweeted
Bariatric surgery was associated with more effective, durable treatment of class II and III obesity at lower costs than #GLP1 receptor agonists.
ja.ma/49H4o1p
Michael Garren, MD retweeted
"What we as a culture have to get back to is being able to have reasonable disagreement—where violence is not an option." — Charlie Kirk.
Michael Garren, MD retweeted
We are beyond thrilled to welcome Drs. Cameron Casson @WashUSurgery (#AbWall) and Yatee Dave @URMCSurgery (#Foregut #Bariatrics) to @WiscSurgery MIS!!
Michael Garren, MD retweeted
Thanks to all the people that make this sort of designation possible. We are continually looking to better the care for patients with overweight and obesity
newsweek.com/rankings/americ…











